-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Aileron Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2018 to Q4 2023.
- Aileron Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2023 was -139 %, a 35.2% decline year-over-year.
- Aileron Therapeutics, Inc. annual Return On Equity for 2023 was -139 %, a 35.2% decline from 2022.
- Aileron Therapeutics, Inc. annual Return On Equity for 2022 was -103 %, a 108% decline from 2021.
- Aileron Therapeutics, Inc. annual Return On Equity for 2021 was -49.5 %, a 76.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)